CP 47,497

From Self-sufficiency
Revision as of 21:10, 21 September 2010 by Jontas (Talk | contribs) (1 revision)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
CP 47,497
240px
Systematic (IUPAC) name
2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl)phenol
Legal status
Legal status
  • Illegal in Germany and France, Class B (UK)
Identifiers
CAS Number 70434-82-1
70434-92-3 (C8 homologue)
PubChem CID 125835
Chemical data
Formula C21H34O2
Molar mass 318.492 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

CP 47,497 is a cannabinoid receptor agonist drug, developed by Pfizer in the 1980s.[1] It has analgesic effects and is used in scientific research. It is a potent CB1 agonist with a Kd of 2.1 nM.[2][3][4]

Homologue

On the 19th of January 2009, the University of Freiburg in Germany announced that an analog of CP 47,497 is the main active ingredient in the herbal "incense" product Spice, specifically the 1,1-dimethyloctyl homologue of CP 47,497. Both the dimethylheptyl and dimethyloctyl homologues were detected in different batches, with considerable variation in the concentration present in different samples that were analysed. The weaker dimethylhexyl and dimethylnonyl homologues were not found in any batches of smoking blends tested, but have been legally scheduled alongside the others in some jurisdictions, to forestall any potential use for this purpose.[5][6][7] The 1,1-dimethyloctyl homologue of CP 47,497 is in fact several times more potent than the parent compound,[8] which is somewhat unexpected as the 1,1-dimethylheptyl is the most potent substituent in classical cannabinoid compounds such as HU-210.[9] The unapproved use of these compounds in herbal smoking blends has led to a resurgence in legitimate scientific research into their use, and consequently the C8 homologue of CP 47,497 has been assigned a proper name, cannabicyclohexanol.[10]

File:Cannabicyclohexanol.png
Cannabicyclohexanol


Legal status

Germany

On the 22nd January 2009, CP 47,497 was added to the German controlled drug schedules ("Betäubungsmittelgesetz"),[11] along with its dimethylhexyl, dimethyloctyl and dimethylnonyl homologues.[12]

France

CP 47,497 and its C6, C8, and C9 homologues were made illegal in France on 24th of February 2009.[13]

Latvia

CP 47,497 and its C6, C8, and C9 homologues were made illegal in Latvia on 28 November 2009.[14]

Lithuania

CP 47,497 and its C6, C8, and C9 homologues were made illegal in Lithuania on 5th of June 2009.[15]

Sweden

CP 47,497 and its C6, C7, C8, and C9 homologues were made illegal in Sweden on 15th of September 2009.

Romania

CP 47,497 and its C6, C7, C8, and C9 homologues were made illegal in Romania on 15th of February 2010.(Illegal Substances in Romania after 15.02.2010

United States

The state of Georgia passed a bill that made CP 47,497 illegal on May 24th 2010. [16] The state of Louisiana passed a bill that made CP 47,497 illegal on August 15th 2010. [17] Dallas and the surrounding area has, for the most part, banned k2 through city ordinances.

References

  1. ↑ Weissman A, Milne GM, Melvin LS Jr. Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. Journal of Pharmacology and Experimental Therapeutics. 1982 Nov;223(2):516-23. PMID 6290642
  2. ↑ Shim JY, Welsh WJ, Howlett AC. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction. Biopolymers. 2003;71(2):169-89. PMID 12767117
  3. ↑ Roger Pertwee. Cannabinoids. Handbook of Experimental Pharmacology Volume 168. Springer. ISBN 3-540-22565-X
  4. ↑ Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. Journal of Pharmacology and Experimental Therapeutics 1988; 247:1046–1051.
  5. ↑ Hauptwirkstoff von „Spice“ identifiziert, University of Freiburg http://www.pr.uni-freiburg.de/pm/2009/pm.2009-01-19.19/
  6. ↑ Spice - weitere Analyseresultate http://www.basg.at/servlet/sls/Tornado/web/ages/content/4E5A4B86295BF5C0C125753E006A5E3C
  7. ↑ Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry. 2009 Feb 2. PMID 19189348
  8. ↑ Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. Journal of Pharmacology and Experimental Therapeutics. 1992 Jan;260(1):201-9. PMID 1309872
  9. ↑ Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry and Behavior. 1991 Nov;40(3):471-8. PMID 1666911
  10. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  11. ↑ Modedroge "Spice" ist verboten!
  12. ↑ BGBl I Nr. 3 vom 21.01.2009, 22. BtMÄndV vom 19. Januar 2009, S. 49–50.
  13. ↑ [1]
  14. ↑ [2]
  15. ↑ http://www3.lrs.lt/pls/inter3/dokpaieska.showdoc_l?p_id=345197
  16. ↑ http://www.legis.ga.gov/legis/2009_10/search/hb1309.htm
  17. ↑ http://www.legis.state.la.us/billdata/byinst.asp?sessionid=10RS&billtype=ACT&billno=866
40px This article about a cannabinoid is a stub. You can help ssf by expanding it.
de:CP-47,497

ru:CP 47,497 sv:CP 47,497

Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=CP_47,497&oldid=40262"